Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Study Analyzes the Effects of Antibiotics on the Gut Flora

Published: Thursday, January 10, 2013
Last Updated: Thursday, January 10, 2013
Bookmark and Share
A study co-led by researchers of the University of Valencia reveals that antibiotics produce changes in the microbial and metabolic patterns of the gut.

The researchers that have analyzed for the first time the bacteria, genes, enzymes and molecules that form the gut microbiota of patients treated with antibiotics publish the results of their study in the online edition of the journal ‘Gut’.

In the gut live one trillion bacteria, which are known as microbiota or gut flora, and that co-evolve in symbiosis with humans. According to this work, treatment with antibiotics can alter this symbiosis from early stages of the treatment.

“Although some of the changes are oscillatory and can be reversed at the end of the treatment, others seem irreversible”, said one of the coordinators of the study, Andrés Moya, who works at Cavanilles Institute of Biodiversity and Evolutionary Biology of the Science Park of the University of Valencia.

The research, which has had the collaboration of the CSIC, the Centre Superior d’Investigació en Salut Pública (CSISP) (Centre for Advanced Research in Public Health), the University CEU San Pablo and the Centre d’Investigació Biomèdica en Xarxa en Epidemiologia i Salut Pública (CIBEResp) (Centre for Biomedical Research in Epidemiology and Public Health), has compared stool samples of a patient taken before and after the treatment.

Changes in gut bacteria

The biodiversity of the bacteria that form the gut microbiota, according to the results, decreases during the treatment to the point of reaching its minimum 11 days after the beginning. However, at the end of the treatment, the situation is reversed and the patient presents a bacterial population similar to the first.

Although the research “shows for the first time that gut bacteria presents a lower capacity to produce proteins, as well as deficiencies in key activities, during and after the treatment”, explains Moya. Specifically, the study suggests that the gut microbiota shows less capacity to absorb iron and digest certain foods as well as to produce essential molecules for the organism.

The research also shows that less abundant bacteria in the gut flora, but little active at the beginning of the treatment, at the end they became active and they may play an important role in the gut as a consequence of the antibiotics, according to Manuel Ferrer, researcher of the CSIC. “These bacteria could be responsible for improving the interconnection between the liver and colon and of the production of essential molecules such as bile acids, hormones and cholesterol derivatives”, say the researchers.

“Only through a comprehensive and detailed analysis of the different antibiotics and people from different geographical origin, age or state of health, can be reached personalized therapies and interventions” concludes Moya.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos